Look the stock is now a 6 billion dollar company and that will put it in the top 50. Funds will have to buy it on that account alone.
The capital financing is a third debt, third share placement and the rest public placement. Say half of the 1.2 billion in expenditures is in dilution, so 600 million is added to the val of the company. 600$million out of 4.2 billion is 14%. The stock should trade 22.5 x 1.14 = $25.6 on opening.
On another level, the company's earnings are growing at a spectacular rate and with acquisitions to add to the earnings, it is hard to now to undervalue future earnings and what discount rate do you use?
Stock is a 30-40 dollar target in 6-12 months.
good luck
- Forums
- ASX - By Stock
- WOR
- beats all analysts predictions again
beats all analysts predictions again
Featured News
Add WOR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$14.56 |
Change
-0.035(0.24%) |
Mkt cap ! $7.656B |
Open | High | Low | Value | Volume |
$14.36 | $14.58 | $14.35 | $5.790M | 400.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 1229 | $14.55 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.56 | 151 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 1144 | 14.540 |
9 | 1339 | 14.530 |
10 | 1343 | 14.520 |
10 | 1664 | 14.510 |
8 | 2157 | 14.500 |
Price($) | Vol. | No. |
---|---|---|
14.550 | 660 | 13 |
14.560 | 2595 | 12 |
14.570 | 2814 | 7 |
14.580 | 2572 | 9 |
14.590 | 4772 | 11 |
Last trade - 13.41pm 13/11/2024 (20 minute delay) ? |
Featured News
WOR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online